Legend Biotech (LEGN) EBT (2019 - 2025)
Legend Biotech (LEGN) posted EBT of -$19.7 million for Q4 2025, up 49.58% on a QoQ basis from -$39.1 million in Q3 2025, and down 148.52% year-over-year from $40.6 million in Q4 2024.
Legend Biotech (LEGN) EBT (2019 - 2025) Analysis & Trends
Legend Biotech's EBT history runs 7 years deep, the most recent figure standing at -$19.7 million for Q4 2025.
- Quarterly EBT fell 148.52% year-over-year to -$19.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$282.7 million (down 78.87% YoY) and the FY2025 annual result came in at -$282.6 million, down 78.71% from the prior year.
- EBT was -$19.7 million for Q4 2025 at Legend Biotech, up from -$39.1 million in the prior quarter.
- Across five years, EBT topped out at $40.6 million in Q4 2024 and bottomed at -$198.8 million in Q2 2023.
- A 5-year average of -$89.6 million and a median of -$93.7 million in 2021 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT sank 33858.75% — and 2024, when it surged 127.65%.
- Legend Biotech's EBT stood at -$88.3 million in 2021, then tumbled by 53.65% to -$135.7 million in 2022, then fell by 8.17% to -$146.8 million in 2023, then jumped by 127.65% to $40.6 million in 2024, then slumped by 148.52% to -$19.7 million in 2025.
- Business Quant data shows LEGN's EBT at -$19.7 million in Q4 2025, -$39.1 million in Q3 2025, and -$124.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | -19.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -19.70 Mn |
| Sep 30, 2025 | -39.07 Mn |
| Jun 30, 2025 | -124.80 Mn |
| Mar 31, 2025 | -99.13 Mn |
| Dec 31, 2024 | 40.60 Mn |
| Sep 30, 2024 | -120.89 Mn |
| Jun 30, 2024 | -17.97 Mn |
| Mar 31, 2024 | -59.79 Mn |
| Dec 31, 2023 | -146.81 Mn |
| Sep 30, 2023 | -62.50 Mn |
| Jun 30, 2023 | -198.84 Mn |
| Mar 31, 2023 | -111.97 Mn |
| Dec 31, 2022 | -135.72 Mn |
| Sep 30, 2022 | -84.80 Mn |
| Jun 30, 2022 | -193.07 Mn |
| Mar 31, 2022 | -32.13 Mn |
| Dec 31, 2021 | -88.33 Mn |
| Sep 30, 2021 | -124.75 Mn |
| Jun 30, 2021 | -172.39 Mn |
| Mar 31, 2021 | -94,603.00 |